Clinical Research Directory
Browse clinical research sites, groups, and studies.
Transplacental Neonatal Transfer of Lidocaine During Urgent Caesarean Delivery
Sponsor: Hôpital de la Croix-Rousse
Summary
Lidocaine is commonly administered through an existing labor epidural catheter to provide surgical anesthesia for urgent cesarean delivery. Lidocaine crosses the placenta, and fetal exposure may be influenced by maternal dose, the interval between epidural administration and delivery, and fetal acid-base status. This prospective multicenter observational cohort study evaluated fetal exposure to lidocaine in women undergoing Lucas category 1 or category 3 cesarean delivery after epidural extension with 2% lidocaine and epinephrine. Lidocaine concentrations were measured in paired umbilical arterial and venous plasma samples collected immediately after delivery. The study compared umbilical cord lidocaine concentrations between the two urgency categories and examined their associations with umbilical pH.
Official title: Transplacental Neonatal Transfer of Lidocaine During Urgent Caesarean Delivery: the Lidocaine TNT Prospective Multicentre Cohort Study
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
95
Start Date
2025-10-01
Completion Date
2026-09-01
Last Updated
2026-09-22
Healthy Volunteers
No
Interventions
Category Lucas 1 cesarian section
Category Lucas 1 cesarian section with the timing of birth \< 15 min
Category 3 Lucas Cesarian section
Urgent cesarian section within 60 min
Locations (1)
Hospices Civils de Lyon
Lyon, France